Clatterbridge Cancer Centre NHS Foundation Trust

Liverpool L7 8YA

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Melanoma, Myelodysplastic Syndromes

Studies at this site

• VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] — Recruiting now
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia — Stopped early